Left ventricular hypertrophy: A potent cardiovascular risk factor and its relationship to office and ambulatory blood pressure

Blood Pressure Monitoring

Volumn 4, Issue SUPPL. 1, 1999, Pages

  Mansoor, George A ^a,c   Massie, Barry M ^b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Ambulatory blood pressure; Left ventricular hypertrophy; Office blood pressure

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MEDICAL EDUCATION; META ANALYSIS; PRIORITY JOURNAL;

BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 0033512622     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castell! WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566.
2. Liebson PR, Grandits G, Pineas R, Dianumbra S, Flack JM, Cutler JA, et al. Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1993; 87:476-486.
3. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated hypertension, ann Intern Med 1991 ;114:345-352.
4. Silberberg JS, Barre PE, Prichard S, Sniderman AD. Left ventricular hypertrophy: an independent determinant of survival in end stage renal failure. Kidney Int 1989; 36:286-290.
5. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS. The prognostic role of left ventricular hypertrophy in patients with and without coronary artery disease. Ann Intern Med 1992; 117:831-836.
6. Aronow WS, Koenigsberg M, Schwartz KS. Usefulness of echocardiographic left ventricular hypertrophy in predicting new coronary events and atherothrombotic brain infarction in patients over 62 years of age. Am J Cardiol 1988; 61:1130-1132.
7. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Echocardiographically detected left ventricular hypertrophy; prevalence and risk factors. Ann Intern Med 1988; 108:7-13.
8. Savage DD, Drayer Jl, Henry WL, Matthews EC, Ware JH, Gardin JM, et al. Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects. Circulation 1979; 59:623-632.
9. Shapiro LM, Mackinnon J, Beevers DG. Echocardiographic features of malignant hypertension. Br Heart J 1981; 46:374-379.
10. Laufer E, Jennings GL, Komer PI, Dewar E. Prevalence of cardiac structural and functional abnormalities in untreated primary hypertension. Hypertension 1989; 13:151-162.
11. Gottdiener JS, Reda DJ, Materson BJ, Massie BM, Notargiacomo A, Hamburger RJ, e( aJ. Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. J Am Coll Cardiol 1994; 24:1492-1498.
12. Fröhlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, et al. The heart in hypertension. N Engl J Med 1992; 327:998-1008.
13. Joint National Committee on Prevention, Detection, Evaluation, and treatment of High blood pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High blood pressure. Arch Intern Med 1997; 157:2413-2446.
14. Devereux RB, Savage DD, Sachs I, Laragh JH. Relation of hemodynamic load to left ventricular hypertrophy and performance in hypertension. Am J Cardiol 1983; 51:171-176.
15. Fagard R, Staessen JA, Thijs L The relationships between left ventricular mass and daytime and nighttime blood pressures: a meta-analysis of comparative studies. J Hypertens 1995; 13:823-829.
16. Harshfield GA, Hwang C, Grim CE. Circadian variation of blood pressure in blacks: influence of age, gender and activity. J Human Hypertens 1990; 4:43-47,
17. Devereux RB, Pickering TG, Harshfield GA, Kleinen HD, Denby L, Clark L, et al. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure responses to regularly recurring stress. Circulation 1983; 68: 470-476.
18. Manda G, Zanchetti A, Agebiti-Rosei E, Benemio G, De Cesaris R, Fogari R, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. Circulation 1997; 95:1464-1470.
19. Fagard RH, Staessen JA, Thijs L Relationship between changes in left ventricular mass and in clinic and ambulatory blood pressure in response to antihypertensive therapy. J Hypertens 1997; 15:1493-1502.
20. Staessen JA, Byttebier G, Buntinx F, Celis H, O'Brien ET, Fagard R. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. JAMA 1997; 278:1065-1072.
21. Schlaich M, Schmieder RE. Left ventricular hypertrophy and its regression: pathophysiology and therapeutic approach; focus on treatment by antihypertensive agents. Am J Hypertens 1998; 11:1394-1404.
22. Schmieder RE, Schlaich MP, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension: a metaanalysis of randomized doubleblind studies. An update including studies until the end of December 1996. Nephrol Dial Transplant 1998; 13:564-569.
23. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi l, et at. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998; 97:48-54.
24. Muiesen ML, Salvetti M, Rizzoni D, Monteduro C, Castellano M, AgabitiRosei E. Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up. J Hypertens 1996; 14:S43-S49.